Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Jun 01, 2020
Braeburn Submits Request for Final Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Mar 11, 2020
Market of Tert-Butyl Alcohol in Russia: Research & Forecast to 2024 - ResearchAndMarkets.com
Jan 29, 2020
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations for Treatment of Pain
Jan 27, 2020
Global Sialorrhea Market Report 2017-2028: Current Treatment Practices, Emerging Drugs, Market Share of Individual Therapies, Current & Forecasted Market Size
Jan 06, 2020
Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%
Dec 26, 2019
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Dec 02, 2019
New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes
Nov 25, 2019
Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence
Nov 14, 2019
Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results
Sep 18, 2019
Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant
Jul 30, 2019
The Government of Canada increases access to treatment for opioid use disorder in Alberta
Jul 23, 2019
Camurus Announces Positive Outcome of U.S. Court Proceeding About Final Approval of Brixadi(TM)
Jul 10, 2019
Orexo Signs License and Supply Agreement With Mundipharma for Zubsolv® in Australia and New Zealand
Feb 01, 2018
SCYNEXIS Presents New In Vivo Data Highlighting the Potential of SCY-078 Used in Combination for the Treatment of Aspergillus Infections at AAA 2018